Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics
|
|
- Winifred Payne
- 6 years ago
- Views:
Transcription
1 Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent Technologies Point Biomedical Corp. Sensant Corp. Agilent Technologies Arnold & Porter Hewlett-Packard Co. Bodri Capital Management Neoguide Systems Cardiogenesis Corp. Pelikan Technologies Hewlett-Packard Co. Percardia Inc. Advanced Technology Point Biomedical Corp. Ventures Sensant Corp. Tissue Link Medical, Inc. Zonare, Inc. Dr. Sidney C. Smith, Jr. Johnson & Johnson Intuitive Surgical Keynote Speaker Dr. William Parmley Task Force Co-Chairs Dr. Joseph S. Alpert Dr. Robert O. Bonow Imaging Takeda King Pharmaceuticals Journal of the American College of Cardiology Vol. 44, No. 8, by the American College of Cardiology and the American Heart Association, Inc. ISSN /04/$30.00 Published by Elsevier Inc. doi: /j.jacc
2 Dr. Robert M. Califf Aventis Inspire Pharmaceuticals Johnson & Johnson King Pharmaceuticals Millennium Novartis Ortho Biotech Proctor and Gamble Quintiles Amgen Berlex Biosite COR Therapeutics Cordis Corgentech Daiichi Esai GE Medical Medicure Millennium NABI Novartis Proctor and Gamble Roche Diagnostics St. Jude Medical Theravance * * * * Novartis* * Nitrox LLC Dr. Pamela S. Douglas General Electric Millennium Pharmaceuticals (spouse only) General Electric General Electric Millennium Pharmaceuticals (spouse employee) Dr. Alice K. Jacobs Wyeth (spouse s employer) Dr. Bruce D. Lindsay Stereotaxis, Inc. Stereotaxis, Inc. Stereotaxis, Inc. Dr. Steve Nissen Sankyo Sankyo Takeda Takeda Eli Lilly & Co. Sanofi Novo Nordisk Sanofi Wyeth Lipid Sciences AtheroGenics, Inc. Dr. James Ritchie Dr. Thomas J. Ryan JACC Vol. 44, No. 8, 2004 Appendix
3 Dr. Kenneth I. Shine Dr. Michael J. Wolk Dr. Douglas P. Zipes Task Force Writers GMP Companies, Inc. Aderis Terumo Cardiovascular Systems Corp. Life Sentry CV Therapeutics Burrill and Company Genzyme Cardiofocus Dr. Robert J. Adams Dr. Jeffrey L. Anderson Schering Novartis Johnson & Johnson/Merck / Alteon Johnson & Johnson/Merck Sanofi Partnership Alteon /Schering Dr. Elliott Antman Aventis Bayer Biosite Boehringer Mannheim British Biotech Centor Cor/Millennium Corvas Dade Genentech Eli Lilly & Co. Sunol Dr. Bruce Bellande Dr. George Beller Imaging Vasomedical Imaging Dr. Melvin D. Cheitlin Johnson & Johnson 1756 Appendix 1 JACC Vol. 44, No. 8, 2004
4 Dr. Anthony DeMaria All echo instrument CardioNet All echo instrument and Biosite, Inc. and contrast Resmed (no salary) contrast companies companies Dr. Gregg C. Fonarow /Sanofi / Sanofi Bristol-Myers Squibb/Sanofi Bristol-Myers Squibb/Sanofi GlaxoSmithKine Bristol-Myers Squibb/Sanofi Dr. Larry B. Goldstein -Parke-Davis -Parke-Davis CuraGen Corp. SPARCL Trial DPharm Johnson & Johnson Research Laboratories Dr. Augustus O. Grant Edward Hines Investors Financial Services Corp.: NASDAQ Shareholder and Board Member Chase Corp. (AMEX) Board Member Dr. John W. Hirshfeld, Jr. Dr. Rae Ellen Kavey David Wm. Livingston, Esq. Christine W. McEntee Dr. Joseph V. Messer Dr. Rick A. Nishimura Dr. E. Magnus Ohman Berkley Schering-Plough Sanofi Millennium JACC Vol. 44, No. 8, 2004 Appendix
5 Dr. Eric D. Peterson Millennium Millennium Bristol-Myers Squibb/Sanofi Partnership CV Therapeutics, Inc. Dr. Bertram Pitt IVAX Pharmaceutical IVAX Pharmaceutical Novartis Keystone Biomedical, Inc. Sankyo Dr. Eric N. Prystowsky Bard Medical CV Therapeutics Stereotaxis, Inc. CardioNet Bard Medical CV Therapeutics, Inc. Stereotaxis, Inc. CardioNet Astra Zeneca CardioNet Dr. Pravin M. Shah Dr. James T. Willerson Encysive Encysive Task Force Participants Dr. Brian H. Annex AnGes MG AnGes MG AnGes MG GenCell/Aventis GenCell/Aventis Valentis Valentis Edwards LifeSciences Genzyme Genzyme Dr. David W. Bilheimer & Co Inc. (employee) Nancy A. Brown Dr. Jay N. Cohn Novartis Novartis NitroMed Hypertension Diagnostics Karen Collishaw Dr. David Faxon Dr. David W. Feigal, Jr. Dr. Lawrence Friedman 1758 Appendix 1 JACC Vol. 44, No. 8, 2004
6 Dr. Robert Frye Abbott Laboratories Bayer Diagnostics Becton Dickinson Medical Imaging Eli Lilly & Co. Fujisawa Healthcare, Inc. Carlson Labs Centocor Incorporated Fournier Pharma Inc. Novartis Pharmaceuticals Roche Laboratories Sanofi-Synthelabo Dr. Valentin Fuster Vasogen Kereos Foundation on CV Disease and Global Advisory Board Dr. Timothy J. Gardner Dr. Arthur Garson, Jr. Dr. Raymond J. Gibbons Less than $10,000 CV Therapeutics King Pharmaceuticals DOV Pharmaceutical Wyeth-Ayerst King Pharmaceuticals Radiant Medical Medicure TherOx Hawaii Biotech Innercool Therapies Boston Scientific TargeGen Molecular Insight TherOx Boehringer Ingelheim Spectranetics KAI Pharmaceuticals TargeGen (pending) JACC Vol. 44, No. 8, 2004 Appendix 1 Lindsay A. Hampson 1759
7 Dr. Robert A. Harrington Proctor & Gamble Norvartis Millenium Alexion Aventis Eli Lilly & Co. Arginox Daiichi The Medicines Company Astra Zeneca Marcia J. Jackson Dr. Harry R. Kimball Dr. David Korn Dr. Joao A. C. Lima Fujisawa Toshiba, Inc. General Electric Medical Systems Amershan Dr. Beverly H. Lorell Corp. (employee & stock holder) Dr. Jon F. Merz Wyeth Dr. Elizabeth Ofili Novartis Novartis Nitromed Sanofi & Co. Dr. Carl J. Pepine Abbott CV Therapeutics Medical Education Consultants, Inc. (MEDCON) King Monarch Pharmaceuticals Abbott Berlex Laboratories, Inc. Astra Zeneca Aventis CV Therapeutics Wyeth-Ayerst Laboratories Medical Education Consultants, Inc. (MEDCON) Dr. Shahbudin H. Rahimtoola 1760 Appendix 1 JACC Vol. 44, No. 8, 2004
8 Dr. Rose Marie Robertson Pharmaceutical (spouse on SAB) Dr. Lynn A. Smaha Dr. L. Samuel Wann Dr. Gayle R. Whitman *Educational activities or lectures for this company generate revenue for Duke. JACC Vol. 44, No. 8, 2004 Appendix
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More informationOwnership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationHeart Valve Summit: Medical, Surgical and Interventional Decision Making
Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More informationDISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationCommittee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
More informationHEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationEarly Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationACC.13 Committee Disclosures Page 1 of 9
ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More information2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationBOARD OF DIRECTORS. PETER WEHRLY Chair
BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationMARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
More informationThe 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
More informationRICHARD BUTLAND Director
RICHARD BUTLAND Richard Butland is the managing partner of Kite Capital, a growth oriented private investment firm. Prior to establishing Kite Capital, Richard spent 15 years at Goldman Sachs where he
More informationTODAY LETTER DATED
TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE-
More informationCardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC
Cardiac Safety Research Consortium: A Decade of CSRC Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC
More informationHESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09
HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!
More informationDisclosures of Relevant Financial Relationships
Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationMonetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
More informationAstellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting Tokyo, Japan March 16, 2010 Astellas Pharma Inc. (TSE: 4503) today notified
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More informationTuesday, December 4, PM to 8PM. Location:
EVENT INFORMATION: The Women in Pharma group of the Boston Area Chapter of ISPE is proud to offer this Bridging the Gap in Gender Diversity event with MassBio. Show Me the Numbers on Gender Diversity in
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationSanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
PRESS RELEASE Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 Paris, France May 23, 2016 - Sanofi Chief Executive Officer Olivier Brandicourt, MD, announced today
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationMATCHING GIFT COMPANY LIST
MATCHING GIFT COMPANY LIST This is a list of corporations that have matched donations to events benefiting Susan G. Komen for the Cure in the past. Please review your corporation s matching gift guidelines
More informationInternational Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs Do you want to strengthen your business plan for your company?, or refresh your
More informationAcknowledgements. Legal Notice
1 Acknowledgements The 2011 EU Industrial R&D Investment Scoreboard (Draft) has been published within the context of the Industrial Research Monitoring and Analysis (IRMA) activities that are jointly carried
More informationWelcome and Introductions
Welcome and Introductions Jeffrey I. Mechanick, MD, FACP, FACE, FACN, ECNU AACE President Clinical Professor of Medicine Director, Metabolic Support Division of Endocrinology, Diabetes, and Bone Disease
More informationFor personal use only
2011 Annual General Meeting December 1, 2011 NASDAQ (UNIS) and ASX (UNS) Cautionary Note Regarding Forward-Looking Statements This presentation contains forward looking statements under the safe harbor
More informationHighland County, Ohio Court Schedule Report from: 6/25/2018 to 7/16/2018 MAGISTRATE CYNTHIA WILLIAMS Monday, June 25, 2018
Monday, June 25, 2018 1 10:00 am 18DS0086 ADAMS, ZACKORY vs ADAMS, JULIE Petitioner 1 Petitioner 2 ADAMS, ZACKORY Hapner, Kathryn ADAMS, JULIE Wednesday, June 27, 2018 2 9:00 am 11DR0148 MURPHY, KRISTIN
More informationBrightening the Day. Friday, May 10, th Annual Benefit Gala. Visiting Nurse Association of Northern New Jersey LIGHTING THE WAY COMMITTEE
LIGHTING THE WAY COMMITTEE CHAIRPERSON Lisa Appleby SILENT AUCTION CO-CHAIRS Patricia Bernal-Silva and Kristin Sostowski Wanda Blake Dale Calvert Elizabeth T. Gilfillan Caroline J. Cauldwell Corporate
More informationNEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH
NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH TABLE OF CONTENTS Cushman & Wakefield 2 3 KEY TAKEAWAYS 4 ECONOMIC IMPACT 5 R&D / FLEX MARKET 6 CLASS A OFFICE MARKET 7 LIFE SCIENCES
More informationTRANSFORMING THE FUTURE
FIRST. TRANSFORMATIVE. PROVEN. TRANSFORMING THE FUTURE NASDAQ : TINY SAFE HARBOR STATEMENT This presentation may contain statements of a forward-looking nature relating to future events. Statements contained
More informationHealthcare Products & Services Industry Update Q2 2017
Healthcare Products & Services Industry Update Q2 2017 Q2 M&A TRANSACTION SUMMARY Q2 Deal Volume (1) Healthcare Products & Services M&A decreased slightly following increased transaction activity in Q1
More informationPHARMA COMPANIES. Bristol-Myers Squibb. CAE Healthcare. Hoffmann-LaRoche
People on themove PHARMA COMPANIES Jacques Dessureault, former General Manager, Med Plan, has been appointed Vice-President, Cardiovascular/Metabolic Business Unit, at Bristol- Myers Squibb. James O. McPherson,
More informationVOLUME ONE PROGRAM SCHEDULE FACULTY BIOS
Prepared for distribution at the TRIAL BY JURY 2013 Program November 20, 2013 CONTENTS: VOLUME ONE PROGRAM SCHEDULE... 1-9 FACULTY BIOS... 1-13 1. ENSURING AN IMPARTIAL JURY IN THE AGE OF SOCIAL MEDIA...
More informationACC.17 Program Committee Disclosures of Relationships With Industry Disclosures
ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen
More information1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner
Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:
More informationEmcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationBecton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationTriton Technology Fund
Triton Technology Fund Presentation to Dean s Engineering Council March 22, 2013 Generate Returns for LPs/GPs Motivation for Fund Catalyze translation of UCSD discoveries for the benefit of society Enable
More informationNektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationwhen it comes to law OPERATIONAL EXPERIENCE Soody Tronson Managing Founder Phone Fax Woodside / Santa Clara
when it comes to law Soody Tronson Managing Founder OPERATIONAL EXPERIENCE soody@stlgip.com Phone 650.275.3913 Fax 866.325.7964 Woodside / Santa Clara www.stlgip.com matters By appointment only https://calendly.com/soody
More informationInvestor s Meeting. Managed by. May 12, Estancia La Jolla Hotel & Spa
Investor s Meeting Managed by May 12, 2009 Estancia La Jolla Hotel & Spa Lead Sponsor and Host: Meet the innovators and companies who are defining the convergence of wireless and biopharmaceuticals, medical
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationAgenda. Genesys Capital Partners. The Opportunity. Our Approach
MEDT Dinner Presentation September 28, 2005 Agenda Genesys Capital Partners The Opportunity Our Approach Genesys Capital Partners Genesys Capital Partners Successful Track Record Management experience
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More informationDeals and Dealmakers. The Health Care M&A Review Fourth Quarter 2017
Deals and Dealmakers The Health Care M&A Review Fourth Quarter 217 Irving Levin Associates Publications and Services Subscriptions & Memberships The SeniorCare Investor www.healthcaremanda.com Dealmakers
More informationEntrepreneurial Impact: The Role of MIT
Entrepreneurial Impact: The Role of MIT Edward B. Roberts & Charles Eesley MIT Sloan School of Management Presented by Edward Roberts Washington, D.C. February 17, 2009 Table 1. Estimated Employment and
More informationNew Rhein concludes successful investment in Chase Pharmaceuticals via sale to Allergan
New Rhein concludes successful investment in Chase Pharmaceuticals via sale to Allergan NEWS PROVIDED BY New Rhein Healthcare Investors LLC Nov 22, 2016, 04:57 ET CHICAGO, Nov. 22, 2016 /PRNewswire/ --
More informationLife Sciences Outlook. New York City 2016
Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and
More information30th Annual Oncology Nurses Symposium
E X H I B I T O R P R O S P E C T U S 30th Annual Oncology Nurses Symposium S E P T E M B E R 2 6-2 9, 2 0 1 0 H I L T O N S A N D I E G O R E S O R T Scripps Conference Services & CME www.scripps.org/conferenceservices
More informationB20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of
More informationVascepa ADCOM Participants and Contact Information
Vascepa ADCOM Participants and Contact Information Public Speakers who gave testimony on behalf of Vascepa Ellen L Marmer, MD Pediatric Cardiology 520 Hartford Vernon Rockville, CT 06066 Phone: (860) 870-9366
More informationCommittee Disclosures Page 1 of 12
TCT@ACC-i2 Program Committee Disclosures Last Name First Name Middle Name Nothing to Grants Abbott J. Dawn X Abizaid Alexandre Abbott, Boston Scientific Angiolillo Dominick J. Eli Lilly, Daiichi-Sankyo,
More informationHall of Fame. Inducting the 2011 Class Into the DTC Hall of Fame
Inducting the 2011 Class Into the DTC DTC Perspectives proudly welcomed four outstanding executives into the DTC Hall of Fame for their significant achievements in advancing DTC communications. The 2011
More informationPHARMA COMPANIES. Abbott Laboratories. Bristol-Myers Squibb
People on themove PHARMA COMPANIES Éric Chenier, former Product Manager, Pediatric Biaxin, has been appointed Product Manager, Biaxin XL, Primary Care Division, at. Sybil Dahan, former General Manager
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More informationBioNJ Life Sciences Human Resource Conference May 14, 2012 Speaker Bios
General Session 1: What Does it Take to Create a Culture of Compliance and Innovation? (Roundtable Discussion) Peter K. Kim Senior Corporate Counsel, Employment Law Group Pfizer Peter K. Kim serves as
More informationGreg Gubitz CEO Gilbert Godin President & COO Winter 2018
INVESTOR PRESENTATION Greg Gubitz CEO Gilbert Godin President & COO Winter 2018 Forward-looking statements Certain statements in this presentation are forward-looking statements. Any statements that express
More informationFor personal use only
ASX:NRT NASDAQ:NVGN Novogen Ltd (Company) ABN 37 063 259 754 Capital Structure Ordinary Shares on issue: 429 M Board of Directors Mr John O Connor Chairman Mr Bryce Carmine Deputy Chairman Dr James Garner
More informationConnecting People, Science and Regulation
Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway Suite 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm
More informationSPONSORSHIP 2009 guide
SPONSORSHIP 2009guide Prix Galien USA Committee The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative therapies. The Prix
More informationVAST RESOURCES. PERSONAL FOCUS.
VAST RESOURCES. PERSONAL FOCUS. Final Employment Review for Smeal MBA Class of 2009 Full-Time Employment 2 Profile for Smeal MBA Class of 2009 Entering Class Size: 86 Mean Prior Work Experience: 56 months
More informationABOUT THE SPEAKER. J. Roderick Heller, III
ABOUT THE SPEAKER J. Roderick Heller, III J. Roderick Heller, III, is President and Chief Executive Officer of the National Corporation for Housing Partnerships, a Congressionally authorized entity created
More informationLast Name First Name In honour /In memory of. Anderson Lance Paul D. Anderson, Jr., 7th Squadron, 34th Bomb Group. 1st Lt. John J.
Anderson Lance Paul D. Anderson, Jr., 7th Squadron, 34th Bomb Group Anonymous 1st Lt. John J. Bloczynski Anonymous In Honour of W. Hal Thorpe From His Loving Sons and Daughters Baer Bill Robert Maxwell
More informationPlease join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you!
INVITATION TO SPONSOR Currently in its eighth year, the North Carolina CEO Forum is an invitation-only leadership event that welcomes 400 senior business, government and non-profit leaders who are committed
More informationCase 2:10-md Document 1901 Filed 04/25/16 Page 1 of 6 PageID #: 25554
Case 2:10-md-02187 Document 1901 Filed 04/25/16 Page 1 of 6 PageID #: 25554 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA CHARLESTON DIVISION IN RE: C. R. BARD, INC., PELVIC
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationAbbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO
Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO FORWARD LOOKING STATEMENT Some statements in this presentation may be forward-looking
More informationHealthcare Focus. Trends in Capital Flows into Healthcare
Healthcare Focus ISSUE 9 VOLUME 1 Fall 2 DRESNER PARTNERS INVESTMENT BANKING Pharmaceuticals Trends in Capital Flows into Healthcare Since the start of the recession (in December 27, according to the National
More informationASLME & Seton Hall University School of Law Fourth Annual Student Health Law Conference - October 22, 2010 Panelist List.
8:30am 9:20am Speaker: Plenary Session: Taking the Health Law Career Path & Hot Hiring Areas in Health Law Peter Leibold: Executive Vice President & Chief Executive Officer, American Health Lawyer s Association
More informationACC.18 ABSTRACT REVIEWERS Disclosures
Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,
More information